Read by QxMD icon Read

Soft tissue sarcoms

A T Falk, L Moureau-Zabotto, M Ouali, N Penel, A Italiano, J-O Bay, T Olivier, M-P Sunyach, P Boudou-Roquette, S Salas, C Le Maignan, A Ducassou, N Isambert, E Kalbacher, C Pan, E Saada, F Bertucci, A Thyss, J Thariat
AIMS: Recent data suggest that patients with pulmonary metastases from sarcomas might benefit from ablation of their metastases. Some data are available regarding osteosarcomas/angiosarcomas and lung metastases. The purpose of this study was to assess the efficacy of local ablative treatment on the survival of patients with oligometastases (one to five lesions, any metastatic site, any grade/histology) from sarcomas. MATERIALS AND METHODS: A multicentric retrospective study of the French Sarcoma Group was conducted in sarcoma patients with oligometastases who were treated between 2000 and 2012...
January 2015: Clinical Oncology: a Journal of the Royal College of Radiologists
R Beverly Raney, Odile Oberlin, David M Parham
We believe that this is the first translation into English of the first description, in French, of a disease previously unknown. JL Riopelle and JP Thériault, both pathologists, reviewed clinical and pathologic findings in six young patients with soft tissue tumors, and contributed autopsy information on four of the patients. Only one patient was initially correctly diagnosed with rhabdomyosarcoma; the other five initially had alternative diagnoses. Because of space limitations, we have condensed the clinical and pathologic details of their 23-page, approximately 9-font article into two Tables, but have otherwise translated the complete text of this seminal paper...
September 2012: Pediatric and Developmental Pathology
N Penel, A Italiano, N Isambert, E Bompas, G Bousquet, F Duffaud
BACKGROUND: To determine whether pulmonary metastasectomy or the addition of ifosfamide/dacarbazine to a doxorubicin-containing regimen offers a survival benefit to adult patients with metastatic leiomyosarcoma. PATIENTS AND METHODS: We retrospectively collected data from 147 patients treated with a doxorubicin-containing regimen from 1998 to 2008. RESULTS: Progression-free survival (PFS) was 6.5 months (range 1-141 months). We did not identify an independent prognostic factor for PFS...
June 2010: Annals of Oncology: Official Journal of the European Society for Medical Oncology
C Le Péchoux, P Pautier, M Delannes, B N Bui, F Bonichon, S Bonvalot, A Chevalier-Place, J-M Coindre, A Le Cesne, P Morice, I Ray-Coquard, E Stöeckle, S Taieb
CONTEXT: The National French Federation of Comprehensive Cancer Centres (FNCLCC) initiated the update of clinical practice guideline for the management of patients with soft tissue sarcoma in collaboration with the French Sarcoma Group (GSF-GETO), specialists from French public universities, general hospitals and private clinics and with the French National Cancer Institute. This work is based on the methodology developed in the "Standards, Options and Recommendations" (SOR) project. OBJECTIVES: To update SOR guidelines for the management of patients with soft tissue sarcoma previously validated in 1995...
June 2006: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
Jacques-Olivier Bay, Isabelle Ray-Coquard, Jérôme Fayette, Serge Leyvraz, Stephane Cherix, Sophie Piperno-Neumann, Christine Chevreau, Nicolas Isambert, Etienne Brain, Georges Emile, Axel Le Cesne, Angela Cioffi, Fabrice Kwiatkowski, Jean-Michel Coindre, Nguyon Binh Bui, Frédéric Peyrade, Nicolas Penel, Jean-Yves Blay
Advanced soft-tissue sarcomas are usually resistant to cytotoxic agents such as doxorubicin and ifosfamide. Antitumor activity has been observed for gemcitabine and docetaxel combination. We conducted a retrospective study on 133 patients (58 males/75 females) with unresectable or metastatic soft-tissue sarcoma. The median age at diagnosis was 51.7 (18-82), with 76 patients with leiomoyosarcoma and 57 patients with other histological subtypes. The initial localizations were limb (44), uterine (32), retroperitoneal (23) and organs or bone (34)...
August 1, 2006: International Journal of Cancer. Journal International du Cancer
M Schwarzbach, F Willeke, A Dimitrakopoulou-Strauss, L G Strauss, G Mechtersheimer, U Hinz, T Lehnert, C Herfarth
Positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose (FDG), carbon-11-labeled aminoisobutyric acid (AIB) and oxygen-15-labeled water (15O-labeled water) was evaluated for imaging soft tissue sarcomas (STS). Eleven pathologically confirmed STS were evaluated by PET using FDG, AIB and 15O-labeled water. All radiotracers showed an increased activity in viable tumor with a significant differentiation from normal tissue (muscle). An increased glucose metabolism in STS allowed a differentiation from normal tissue (muscle) with FDG...
1998: Langenbecks Archiv Für Chirurgie. Supplement. Kongressband
R E McAfee
No abstract text is available yet for this article.
April 1975: Journal of the Maine Medical Association
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"